Damora Therapeutics (DMRA) Enterprise Value (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Damora Therapeutics | 853.36 Mn | 650.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.44% |
| Dec 31, 2025 | -3,289.79% |
| Sep 30, 2025 | 25.49% |
| Jun 30, 2025 | 14.57% |
| Mar 31, 2025 | 15.77% |
| Dec 31, 2024 | -60.06% |
| Sep 30, 2024 | 61.33% |
| Jun 30, 2024 | 3.13% |
| Mar 31, 2024 | 36.07% |
| Dec 31, 2023 | 39.43% |
| Sep 30, 2023 | -17.13% |
| Jun 30, 2023 | 2.11% |
| Mar 31, 2023 | 11.59% |
| Dec 31, 2022 | 12.82% |
| Sep 30, 2022 | 12.58% |
| Jun 30, 2022 | 15.57% |
| Mar 31, 2022 | 6.58% |
| Dec 31, 2021 | 32.84% |
| Sep 30, 2021 | -46.52% |
| Jun 30, 2021 | 7.72% |
| Mar 31, 2021 | 32.56% |
| Dec 31, 2020 | -91.72% |
| Sep 30, 2020 | -138.07% |
| Jun 30, 2020 | 16.21% |
| Mar 31, 2020 | -278.78% |
| Dec 31, 2019 | 23.14% |